Free Trial

HealthStream (HSTM) Financials

HealthStream logo
$28.16 +0.10 (+0.34%)
As of 12:53 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for HealthStream

Annual Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
20 15 12 5.85 14 16 32 10 3.76 8.62 10
Consolidated Net Income / (Loss)
20 15 12 5.85 14 16 32 10 3.76 8.62 10
Net Income / (Loss) Continuing Operations
20 15 12 5.85 14 14 13 8.84 4.79 8.62 10
Total Pre-Tax Income
25 19 16 7.77 18 18 17 10 7.75 14 17
Total Operating Income
21 16 12 8.06 16 15 15 9.41 7.17 14 16
Total Gross Profit
194 184 176 166 155 150 136 128 117 120 97
Total Revenue
292 279 267 257 245 254 232 215 192 209 171
Operating Revenue
292 279 267 257 245 254 232 215 192 209 171
Total Cost of Revenue
98 95 91 91 89 104 96 87 75 89 74
Operating Cost of Revenue
98 95 91 91 89 104 96 87 75 89 74
Total Operating Expenses
172 168 163 158 140 136 120 118 110 106 80
Selling, General & Admin Expense
35 36 37 40 42 41 34 31 30 29 23
Marketing Expense
47 46 44 39 35 38 36 39 35 36 30
Research & Development Expense
49 46 44 42 32 29 26 24 24 24 16
Depreciation Expense
41 41 38 37 30 28 24 24 20 17 11
Total Other Income / (Expense), net
3.52 2.49 3.14 -0.29 2.01 3.21 1.08 0.73 0.58 0.16 0.15
Interest & Investment Income
3.83 2.36 0.44 - - - - - - - -
Other Income / (Expense), net
-0.32 0.14 2.69 -0.29 2.01 3.21 1.08 0.73 0.58 0.16 0.15
Income Tax Expense
4.80 3.30 3.49 1.92 3.73 3.73 3.32 1.30 2.96 5.10 6.13
Basic Earnings per Share
$0.66 $0.50 $0.39 $0.19 $0.44 $0.49 $1.00 $0.31 $0.12 $0.29 $0.38
Weighted Average Basic Shares Outstanding
30.39M 30.57M 30.65M 31.53M 31.96M 32.37M 32.26M 31.86M 31.72M 30.06M 27.57M
Diluted Earnings per Share
$0.66 $0.50 $0.39 $0.18 $0.44 $0.49 $1.00 $0.31 $0.12 $0.28 $0.37
Weighted Average Diluted Shares Outstanding
30.54M 30.67M 30.72M 31.62M 31.99M 32.43M 32.34M 32.20M 32.07M 30.44M 28.02M
Weighted Average Basic & Diluted Shares Outstanding
30.43M 30.30M 30.58M 30.94M 31.49M 32.38M 32.20M 32.30M 31.30M 29.70M 27.40M
Cash Dividends to Common per Share
$0.11 $0.10 $0.00 $0.00 - - $1.00 - - - -

Quarterly Income Statements for HealthStream

This table shows HealthStream's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
4.89 5.73 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Consolidated Net Income / (Loss)
4.89 5.73 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Net Income / (Loss) Continuing Operations
4.89 5.73 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Total Pre-Tax Income
5.48 7.48 5.30 6.54 5.42 5.45 4.50 3.14 3.27 4.93
Total Operating Income
4.69 6.50 4.41 5.69 4.26 4.86 4.01 2.89 3.08 2.38
Total Gross Profit
49 49 48 48 47 47 46 45 45 44
Total Revenue
74 73 72 73 71 70 69 69 69 67
Operating Revenue
74 73 72 73 71 70 69 69 69 67
Total Cost of Revenue
25 24 24 25 24 24 24 24 24 23
Operating Cost of Revenue
25 24 24 25 24 24 24 24 24 23
Total Operating Expenses
44 42 43 42 42 42 42 42 42 42
Selling, General & Admin Expense
8.81 8.46 9.56 8.31 8.44 9.30 9.06 8.87 9.01 9.10
Marketing Expense
12 11 11 12 11 11 11 12 11 11
Research & Development Expense
13 12 12 12 12 11 11 12 12 11
Depreciation Expense
10 10 10 10 11 10 10 9.93 9.61 9.59
Total Other Income / (Expense), net
0.79 0.98 0.89 0.85 1.16 0.59 0.49 0.25 0.19 2.54
Other Income / (Expense), net
-3.04 0.98 0.89 0.85 -1.20 0.59 0.49 0.25 -0.25 2.54
Income Tax Expense
0.59 1.75 1.13 1.32 0.83 1.59 0.37 0.52 0.82 1.26
Basic Earnings per Share
$0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Weighted Average Basic Shares Outstanding
30.39M 30.41M 30.40M 30.31M 30.57M 30.68M 30.68M 30.59M 30.65M 30.57M
Diluted Earnings per Share
$0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Weighted Average Diluted Shares Outstanding
30.54M 30.59M 30.53M 30.42M 30.67M 30.77M 30.78M 30.66M 30.72M 30.66M
Weighted Average Basic & Diluted Shares Outstanding
30.43M 30.41M 30.41M 30.40M 30.30M 30.29M 30.69M 30.68M 30.58M 30.57M
Cash Dividends to Common per Share
$0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 $0.03 - $0.00

Annual Cash Flow Statements for HealthStream

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
19 -5.69 -0.88 10 -95 -2.78 50 35 -32 0.02 22
Net Cash From Operating Activities
58 64 51 42 36 66 43 47 24 35 34
Net Cash From Continuing Operating Activities
58 64 51 42 36 66 44 43 24 35 34
Net Income / (Loss) Continuing Operations
20 15 12 5.85 14 14 13 8.84 4.79 8.62 10
Consolidated Net Income / (Loss)
20 15 12 5.85 14 16 32 10 3.76 8.62 10
Depreciation Expense
41 41 38 37 30 28 24 24 20 17 11
Amortization Expense
12 11 11 9.17 8.77 8.31 7.66 - - - -
Non-Cash Adjustments To Reconcile Net Income
5.66 4.24 1.07 5.40 -1.73 4.32 4.03 3.72 3.17 2.00 0.09
Changes in Operating Assets and Liabilities, net
-22 -8.06 -11 -15 -15 11 -4.92 6.00 -4.44 7.30 13
Net Cash From Investing Activities
-34 -57 -28 -26 -110 -68 37 -12 -57 -135 -16
Net Cash From Continuing Investing Activities
-34 -57 -28 -26 -110 -68 37 -8.82 -56 -135 -16
Purchase of Property, Plant & Equipment
-28 -28 -25 -25 -19 -37 -18 -15 -14 -15 -10
Acquisitions
-1.30 -6.62 -3.97 -4.71 -121 -27 0.00 -0.50 -55 -89 -13
Purchase of Investments
-74 -50 -13 -6.97 -62 -91 -58 -83 -107 -85 -45
Sale of Property, Plant & Equipment
0.00 0.00 0.03 0.00 0.00 0.02 0.00 - 0.98 - -
Sale and/or Maturity of Investments
70 28 14 11 92 81 69 90 119 55 53
Net Cash From Financing Activities
-4.52 -13 -24 -6.21 -20 -0.92 -30 0.00 0.05 100 3.74
Net Cash From Continuing Financing Activities
-4.52 -13 -24 -6.21 -20 -0.92 -30 0.00 0.05 100 3.74
Repayment of Debt
0.00 -0.12 0.00 0.00 - - -0.10 - - -28 -
Repurchase of Common Equity
0.00 -8.93 -23 -5.01 -20 0.00 0.00 - - - -
Payment of Dividends
-3.40 -3.06 0.00 -0.02 -0.04 -0.10 -32 - - -0.63 -0.42
Other Financing Activities, net
-1.11 -0.93 -0.57 -1.18 -0.44 -0.82 2.24 0.00 0.05 2.58 4.17
Effect of Exchange Rate Changes
-0.04 -0.02 0.02 -0.11 0.06 - - - - - -
Cash Interest Paid
0.10 0.13 0.10 0.13 0.10 0.10 0.12 0.10 0.08 0.19 0.06
Cash Income Taxes Paid
8.70 2.61 0.72 -0.09 0.88 0.63 17 0.64 2.50 2.65 1.64

Quarterly Cash Flow Statements for HealthStream

This table details how cash moves in and out of HealthStream's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
1.98 11 -6.28 12 -3.79 18 -23 2.81 -2.23 11
Net Cash From Operating Activities
11 19 6.45 21 14 25 4.95 21 8.11 15
Net Cash From Continuing Operating Activities
11 19 6.45 21 14 25 4.95 21 8.11 15
Net Income / (Loss) Continuing Operations
4.89 5.72 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Consolidated Net Income / (Loss)
4.89 5.72 4.17 5.23 4.59 3.87 4.13 2.62 2.45 3.67
Depreciation Expense
10 10 10 10 11 10 10 9.93 9.61 9.59
Amortization Expense
3.42 3.10 3.00 2.96 3.03 3.00 2.75 2.71 2.77 2.80
Non-Cash Adjustments To Reconcile Net Income
1.40 0.97 2.37 0.92 0.81 1.13 1.11 1.20 1.03 -1.67
Changes in Operating Assets and Liabilities, net
-9.01 -0.76 -13 1.50 -5.14 6.27 -13 4.08 -7.75 0.71
Net Cash From Investing Activities
-8.07 -6.87 -12 -7.12 -9.38 -3.92 -26 -17 -10 -4.05
Net Cash From Continuing Investing Activities
-8.07 -6.87 -12 -7.12 -9.38 -3.92 -26 -17 -10 -4.05
Purchase of Property, Plant & Equipment
-6.84 -6.84 -6.71 -7.76 -6.60 -6.72 -6.25 -8.45 -6.14 -5.96
Acquisitions
-1.30 - - 0.00 - - - -6.62 0.04 -
Purchase of Investments
-23 -17 -20 -14 -12 -6.25 -29 -2.85 -7.87 -3.58
Sale and/or Maturity of Investments
23 17 15 15 9.25 9.05 9.00 1.00 3.60 5.49
Net Cash From Financing Activities
-1.03 -0.92 -0.86 -1.70 -8.27 -2.44 -1.54 -0.79 -0.05 -0.02
Net Cash From Continuing Financing Activities
-1.03 -0.92 -0.86 -1.70 -8.27 -2.44 -1.54 -0.79 -0.05 -0.02
Payment of Dividends
-0.85 -0.85 -0.85 -0.85 -0.76 -0.77 -1.53 0.00 - -
Other Financing Activities, net
-0.18 -0.07 -0.01 -0.86 -0.12 -0.02 -0.01 -0.79 -0.05 -0.02
Effect of Exchange Rate Changes
-0.08 0.04 0.04 -0.04 0.05 0.01 -0.06 -0.02 0.07 0.01

Annual Balance Sheets for HealthStream

This table presents HealthStream's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
511 500 498 487 500 442 411 396 380 257
Total Current Assets
153 130 114 107 115 241 200 177 210 175
Cash & Equivalents
59 40 46 47 37 134 85 50 82 82
Short-Term Investments
38 31 7.89 5.04 9.93 34 46 54 67 39
Accounts Receivable
35 38 43 35 46 41 38 47 36 33
Prepaid Expenses
18 18 15 9.16 9.57 14 16 18 14 13
Other Current Assets
2.47 3.03 2.65 11 13 18 8.33 8.69 8.17 5.77
Plant, Property, & Equipment, net
11 13 15 18 22 16 8.09 10 12 9.44
Total Noncurrent Assets
347 357 368 362 363 185 203 208 158 73
Goodwill
191 191 192 183 178 86 86 110 83 42
Intangible Assets
99 109 119 122 127 78 85 95 70 28
Other Noncurrent Operating Assets
57 57 52 50 50 17 0.75 0.60 0.93 2.04
Total Liabilities & Shareholders' Equity
511 500 498 487 500 442 411 396 380 257
Total Liabilities
151 159 164 148 166 123 111 110 99 89
Total Current Liabilities
116 118 117 100 119 107 101 95 89 77
Accounts Payable
6.63 7.47 7.29 5.13 9.33 8.50 4.18 3.13 4.62 4.75
Accrued Expenses
15 18 30 21 29 32 22 21 16 16
Current Deferred Revenue
84 84 79 74 81 66 65 69 65 54
Current Employee Benefit Liabilities
9.51 9.49 - - - - 2.76 1.99 3.31 2.31
Total Noncurrent Liabilities
36 41 46 47 47 16 9.88 15 10 12
Noncurrent Deferred Revenue
1.66 2.17 2.94 1.58 1.60 2.87 6.29 7.86 4.35 3.66
Noncurrent Deferred & Payable Income Tax Liabilities
15 16 18 18 15 11 - 5.97 4.76 5.84
Other Noncurrent Operating Liabilities
19 23 26 28 31 2.21 1.05 1.10 1.06 2.65
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
359 341 334 339 334 319 300 286 280 168
Total Preferred & Common Equity
359 341 334 339 334 319 300 286 280 168
Preferred Stock
0.00 0.00 - - - - - - - -
Total Common Equity
359 341 334 339 334 319 300 286 280 168
Common Stock
252 249 255 271 272 287 283 281 279 175
Retained Earnings
109 92 80 68 62 32 18 5.35 1.59 -7.03
Accumulated Other Comprehensive Income / (Loss)
-2.05 -0.69 -0.98 0.11 0.00 -0.02 -0.04 -0.05 -0.07 -0.04

Quarterly Balance Sheets for HealthStream

This table presents HealthStream's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
503 500 512 498 493 503 481
Total Current Assets
146 139 147 127 118 125 104
Cash & Equivalents
57 46 52 44 26 49 48
Short-Term Investments
37 37 31 28 30 9.82 3.59
Accounts Receivable
32 36 44 35 41 47 33
Prepaid Expenses
16 17 18 11 9.88 11 9.26
Other Current Assets
3.16 3.12 2.09 9.51 11 8.21 11
Plant, Property, & Equipment, net
11 12 13 14 14 15 16
Total Noncurrent Assets
346 349 352 358 361 363 361
Long-Term Investments
3.98 4.05 4.10 4.19 4.28 4.39 4.64
Goodwill
191 191 191 191 191 191 188
Intangible Assets
100 103 106 111 114 118 117
Other Noncurrent Operating Assets
51 51 51 51 51 50 51
Total Liabilities & Shareholders' Equity
503 500 512 498 493 503 481
Total Liabilities
147 150 167 156 153 167 151
Total Current Liabilities
111 112 126 115 109 121 105
Accounts Payable
4.44 5.81 5.31 3.52 22 20 22
Accrued Expenses
23 19 22 28 5.24 6.53 5.61
Current Deferred Revenue
83 87 98 83 82 94 78
Total Noncurrent Liabilities
37 38 41 41 44 46 46
Capital Lease Obligations
18 19 19 - - - -
Noncurrent Deferred Revenue
1.67 1.89 2.08 2.74 2.26 2.56 1.26
Noncurrent Deferred & Payable Income Tax Liabilities
15 16 17 15 17 19 19
Other Noncurrent Operating Liabilities
1.99 2.22 2.25 23 24 25 26
Total Equity & Noncontrolling Interests
355 349 345 342 341 336 330
Total Preferred & Common Equity
355 349 345 342 341 336 330
Total Common Equity
355 349 345 342 341 336 330
Common Stock
251 250 249 255 256 255 254
Retained Earnings
105 100 97 89 85 82 78
Accumulated Other Comprehensive Income / (Loss)
-0.88 -1.22 -1.17 -1.24 -0.89 -1.02 -1.42

Annual Metrics And Ratios for HealthStream

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.51% 4.59% 3.94% 4.85% -3.65% 9.71% 7.78% 11.85% -8.08% 22.45% 29.04%
EBITDA Growth
8.68% 7.92% 18.49% -5.34% 4.95% 11.63% 41.76% 21.58% -8.46% 11.89% 20.97%
EBIT Growth
29.80% 6.70% 94.97% -56.43% -0.59% 8.17% 63.46% 30.81% -43.49% -16.96% 11.31%
NOPAT Growth
30.43% 36.31% 59.31% -51.52% 7.30% -5.89% 51.05% 85.00% -47.98% -17.31% 23.85%
Net Income Growth
31.51% 25.82% 106.86% -58.52% -10.65% -51.05% 222.04% 166.42% -56.44% -17.06% 23.47%
EPS Growth
32.00% 28.21% 116.67% -59.09% -10.20% -51.00% 222.58% 158.33% -57.14% -24.32% 23.33%
Operating Cash Flow Growth
-9.86% 24.97% 20.77% 18.15% -45.36% 51.82% -7.42% 92.75% -30.60% 1.93% 26.62%
Free Cash Flow Firm Growth
28.50% 36.54% 107.98% 105.99% -3,841.91% -50.03% -87.29% 199.84% 35.80% -1,353.20% -8.50%
Invested Capital Growth
-2.77% -2.18% -1.57% -0.25% 80.65% 5.89% 4.52% -21.85% 40.69% 182.92% 10.79%
Revenue Q/Q Growth
1.27% 0.74% 1.60% 0.99% -0.36% 1.14% 2.01% 16.47% -13.89% 5.30% 5.10%
EBITDA Q/Q Growth
-4.40% 1.42% 6.83% -0.73% -3.01% 2.88% 24.50% 7.37% -4.44% -1.13% 6.37%
EBIT Q/Q Growth
-15.24% -1.27% 28.13% -17.39% -13.92% 1.92% 13.08% 5.88% -9.86% -13.86% 4.37%
NOPAT Q/Q Growth
3.34% 11.04% 38.42% -17.47% -14.06% 6.10% -4.89% 36.77% -18.61% -9.77% 9.55%
Net Income Q/Q Growth
1.51% 16.38% 30.64% -18.31% -16.38% 6.00% -3.47% 74.16% -36.12% -8.82% 9.33%
EPS Q/Q Growth
1.54% 16.28% 34.48% -21.74% -18.52% 8.89% -2.91% 72.22% -33.33% -15.15% 12.12%
Operating Cash Flow Q/Q Growth
-4.40% 9.79% 4.40% 1.99% -18.21% -1.99% 8.52% 4.00% -0.60% 12.27% 5.34%
Free Cash Flow Firm Q/Q Growth
196.57% -1.14% 116.51% 107.83% -954.31% 155.44% -86.12% 136.75% -1.57% 2.61% 87.88%
Invested Capital Q/Q Growth
-4.52% 1.27% 0.67% 2.46% 56.22% 0.61% 6.32% -16.67% -1.58% -1.99% 0.70%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
66.42% 65.95% 65.84% 64.54% 63.51% 59.12% 58.55% 59.42% 60.98% 57.23% 56.56%
EBITDA Margin
25.61% 24.63% 23.87% 20.94% 23.19% 21.29% 20.92% 15.91% 14.64% 14.70% 16.08%
Operating Margin
7.30% 5.74% 4.67% 3.14% 6.46% 5.79% 6.69% 4.38% 3.73% 6.49% 9.59%
EBIT Margin
7.19% 5.79% 5.67% 3.03% 7.28% 7.06% 7.16% 4.72% 4.03% 6.56% 9.68%
Profit (Net Income) Margin
6.86% 5.45% 4.53% 2.28% 5.76% 6.21% 13.91% 4.66% 1.95% 4.12% 6.09%
Tax Burden Percent
80.66% 82.18% 77.58% 75.26% 79.06% 87.96% 194.37% 98.66% 48.44% 62.84% 62.91%
Interest Burden Percent
118.28% 114.58% 102.93% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
19.34% 17.82% 22.42% 24.74% 20.94% 20.82% 20.05% 12.84% 38.20% 37.16% 37.09%
Return on Invested Capital (ROIC)
6.46% 4.83% 3.48% 2.16% 5.74% 7.71% 8.63% 5.12% 2.88% 9.86% 23.99%
ROIC Less NNEP Spread (ROIC-NNEP)
3.09% 1.67% -0.67% 2.55% 8.84% -41.27% -3.32% 3.77% 3.41% 9.78% 23.91%
Return on Net Nonoperating Assets (RNNOA)
-0.74% -0.32% 0.12% -0.43% 2.70% 2.17% 1.78% -1.71% -1.56% -6.01% -17.44%
Return on Equity (ROE)
5.72% 4.51% 3.59% 1.74% 8.44% 9.89% 10.41% 3.41% 1.33% 3.85% 6.55%
Cash Return on Invested Capital (CROIC)
9.27% 7.04% 5.06% 2.41% -51.74% 2.00% 4.20% 29.65% -30.93% -85.68% 13.76%
Operating Return on Assets (OROA)
4.15% 3.24% 3.08% 1.57% 3.60% 3.85% 3.89% 2.51% 2.00% 4.31% 7.03%
Return on Assets (ROA)
3.96% 3.05% 2.46% 1.18% 2.85% 3.39% 7.55% 2.48% 0.97% 2.71% 4.42%
Return on Common Equity (ROCE)
5.72% 4.51% 3.59% 1.74% 8.44% 9.89% 10.41% 3.41% 1.33% 3.85% 6.55%
Return on Equity Simple (ROE_SIMPLE)
5.57% 4.46% 3.62% 1.72% 4.22% 0.00% 10.10% 3.33% 1.31% 3.08% 6.19%
Net Operating Profit after Tax (NOPAT)
17 13 9.66 6.06 13 12 12 8.20 4.43 8.52 10
NOPAT Margin
5.89% 4.72% 3.62% 2.36% 5.11% 4.59% 5.35% 3.82% 2.31% 4.08% 6.04%
Net Nonoperating Expense Percent (NNEP)
3.37% 3.16% 4.14% -0.39% -3.11% 48.98% 11.95% 1.36% -0.52% 0.07% 0.08%
Return On Investment Capital (ROIC_SIMPLE)
4.78% 3.86% 2.89% - - - - - - - -
Cost of Revenue to Revenue
33.58% 34.05% 34.16% 35.46% 36.49% 40.88% 41.45% 40.58% 39.02% 42.77% 43.44%
SG&A Expenses to Revenue
12.05% 12.78% 13.82% 15.46% 17.11% 15.97% 14.87% 14.65% 15.85% 14.00% 13.42%
R&D to Revenue
16.76% 16.32% 16.59% 16.23% 13.20% 11.46% 11.11% 11.24% 12.61% 11.59% 9.65%
Operating Expenses to Revenue
59.12% 60.21% 61.18% 61.40% 57.05% 53.32% 51.86% 55.04% 57.25% 50.75% 46.97%
Earnings before Interest and Taxes (EBIT)
21 16 15 7.77 18 18 17 10 7.75 14 17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
75 69 64 54 57 54 48 34 28 31 27
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.69 2.39 2.26 2.44 2.06 2.59 2.43 2.34 2.65 2.37 4.62
Price to Tangible Book Value (P/TBV)
13.97 20.03 32.76 23.67 24.29 5.66 5.00 5.43 9.27 5.21 7.88
Price to Revenue (P/Rev)
3.32 2.92 2.82 3.22 2.81 3.44 3.35 3.27 3.94 3.17 4.55
Price to Earnings (P/E)
48.34 53.60 62.31 141.33 48.75 55.45 24.06 70.33 201.66 76.91 74.65
Dividend Yield
0.43% 0.37% 0.00% 0.00% 0.00% 0.00% 4.17% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.07% 1.87% 1.61% 0.71% 2.05% 1.80% 4.16% 1.42% 0.50% 1.30% 1.34%
Enterprise Value to Invested Capital (EV/IC)
3.32 2.76 2.52 2.74 2.26 4.47 4.11 4.05 3.62 4.00 14.47
Enterprise Value to Revenue (EV/Rev)
2.98 2.67 2.60 2.99 2.59 2.73 2.60 2.65 3.39 2.44 3.83
Enterprise Value to EBITDA (EV/EBITDA)
11.65 10.83 10.91 14.27 11.16 12.84 12.44 16.63 23.15 16.62 23.79
Enterprise Value to EBIT (EV/EBIT)
41.49 46.07 45.90 98.78 35.55 38.75 36.38 56.08 83.95 37.21 39.54
Enterprise Value to NOPAT (EV/NOPAT)
50.67 56.53 71.95 126.53 50.67 59.61 48.69 69.36 146.84 59.92 63.40
Enterprise Value to Operating Cash Flow (EV/OCF)
15.09 11.63 13.58 18.10 17.66 10.58 13.94 12.17 26.85 14.62 19.07
Enterprise Value to Free Cash Flow (EV/FCFF)
35.29 38.79 49.46 113.55 0.00 230.44 99.93 11.98 0.00 0.00 110.55
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.24 -0.19 -0.17 -0.17 0.31 -0.05 -0.54 -0.45 -0.46 -0.61 -0.73
Leverage Ratio
1.44 1.48 1.46 1.47 2.96 2.92 1.38 1.38 1.37 1.42 1.48
Compound Leverage Factor
1.71 1.69 1.51 1.47 2.96 2.92 1.38 1.38 1.37 1.42 1.48
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 0.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
4.93 4.03 3.62 4.15 3.25 0.00 4.90 4.76 4.95 5.07 6.50
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.32 1.10 0.98 1.06 0.96 2.14 2.26 1.98 1.87 2.35 2.26
Quick Ratio
1.15 0.93 0.82 0.87 0.78 1.93 1.96 1.67 1.59 2.10 2.02
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
25 19 14 6.76 -113 3.02 6.03 47 -48 -74 5.91
Operating Cash Flow to CapEx
204.89% 228.42% 204.13% 167.23% 190.79% 179.91% 234.40% 309.11% 189.18% 227.34% 335.78%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.56 0.54 0.52 0.49 0.55 0.54 0.53 0.50 0.66 0.73
Accounts Receivable Turnover
7.91 6.88 6.87 6.34 6.40 7.12 5.86 5.03 4.59 6.01 5.84
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
24.56 19.59 15.96 12.78 0.00 0.00 19.34 23.44 16.92 19.08 18.47
Accounts Payable Turnover
13.90 12.88 14.69 12.59 0.00 0.00 15.15 23.88 19.36 19.08 20.99
Days Sales Outstanding (DSO)
46.16 53.07 53.10 57.60 57.01 51.26 62.26 72.53 79.54 60.70 62.53
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
26.26 28.33 24.86 28.99 0.00 0.00 24.09 15.29 18.85 19.13 17.39
Cash Conversion Cycle (CCC)
19.90 24.74 28.24 28.61 57.01 51.26 38.17 57.24 60.69 41.57 45.14
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
262 270 276 280 281 155 147 140 180 128 45
Invested Capital Turnover
1.10 1.02 0.96 0.92 1.12 1.68 1.61 1.34 1.25 2.42 3.98
Increase / (Decrease) in Invested Capital
-7.48 -6.02 -4.39 -0.69 125 8.64 6.35 -39 52 83 4.39
Enterprise Value (EV)
870 744 695 767 634 695 603 569 651 510 653
Market Capitalization
967 815 753 826 687 874 775 704 757 663 776
Book Value per Share
$11.82 $11.25 $10.93 $10.74 $10.55 $0.00 $9.87 $9.41 $9.01 $8.86 $6.07
Tangible Book Value per Share
$2.28 $1.34 $0.75 $1.11 $0.89 $0.00 $4.80 $4.06 $2.57 $4.02 $3.56
Total Capital
359 341 334 339 334 0.00 319 300 286 280 168
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-97 -71 -58 -59 -53 -180 -172 -135 -106 -153 -123
Capital Expenditures (CapEx)
28 28 25 25 19 36 18 15 13 15 10
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-60 -59 -57 -45 -51 -53 -34 -32 -21 -29 -24
Debt-free Net Working Capital (DFNWC)
37 12 -2.84 6.50 -4.72 119 135 99 82 120 97
Net Working Capital (NWC)
37 12 -2.84 6.50 -4.72 119 135 99 82 120 97
Net Nonoperating Expense (NNE)
-2.84 -2.05 -2.43 0.22 -1.59 -4.11 -20 -1.80 0.68 -0.10 -0.09
Net Nonoperating Obligations (NNO)
-97 -71 -58 -59 -53 155 -172 -160 -106 -153 -123
Total Depreciation and Amortization (D&A)
54 53 49 46 39 36 32 24 20 17 11
Debt-free, Cash-free Net Working Capital to Revenue
-20.50% -21.24% -21.27% -17.71% -20.92% -21.05% -14.78% -15.10% -10.78% -13.65% -13.84%
Debt-free Net Working Capital to Revenue
12.83% 4.25% -1.06% 2.53% -1.93% 46.98% 58.10% 45.91% 42.92% 57.64% 57.03%
Net Working Capital to Revenue
12.83% 4.25% -1.06% 2.53% -1.93% 46.98% 58.10% 45.91% 42.92% 57.64% 57.03%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.66 $0.50 $0.39 $0.19 $0.44 $0.49 $1.00 $0.31 $0.12 $0.29 $0.38
Adjusted Weighted Average Basic Shares Outstanding
30.39M 30.57M 30.65M 31.53M 31.96M 32.37M 32.26M 31.86M 31.72M 30.06M 27.57M
Adjusted Diluted Earnings per Share
$0.66 $0.50 $0.39 $0.18 $0.44 $0.49 $1.00 $0.31 $0.12 $0.28 $0.37
Adjusted Weighted Average Diluted Shares Outstanding
30.54M 30.67M 30.72M 31.62M 31.99M 32.43M 32.34M 32.20M 32.07M 30.44M 28.02M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
30.43M 30.30M 30.58M 30.94M 31.49M 32.38M 32.33M 32.04M 31.78M 31.65M 27.68M
Normalized Net Operating Profit after Tax (NOPAT)
17 13 9.66 6.06 13 12 12 8.20 4.43 8.52 10
Normalized NOPAT Margin
5.89% 4.72% 3.62% 2.36% 5.11% 4.59% 5.35% 3.82% 2.31% 4.08% 6.04%
Pre Tax Income Margin
8.50% 6.63% 5.84% 3.03% 7.28% 7.06% 7.16% 4.72% 4.03% 6.56% 9.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.01% 20.10% 0.00% 0.33% 0.28% 0.61% 100.55% 0.00% 0.00% 7.34% 4.08%
Augmented Payout Ratio
17.01% 78.79% 191.36% 86.01% 142.35% 0.61% 100.55% 0.00% 0.00% 7.34% 4.08%

Quarterly Metrics And Ratios for HealthStream

This table displays calculated financial ratios and metrics derived from HealthStream's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
5.18% 3.92% 3.41% 5.53% 2.98% 4.54% 5.42% 5.48% 6.53% 4.98%
EBITDA Growth
-6.52% 9.53% 6.84% 25.71% 9.24% 8.92% 12.03% 1.37% 36.53% 30.99%
EBIT Growth
-46.19% 37.15% 17.78% 108.31% 8.35% 10.72% 23.90% -16.44% 666.13% 192.11%
NOPAT Growth
15.88% 44.23% -5.77% 88.28% 56.38% 94.50% 46.86% -22.26% 814.80% 11.65%
Net Income Growth
6.47% 48.05% 0.85% 99.28% 87.42% 5.48% 34.06% -9.33% 732.82% 144.40%
EPS Growth
6.67% 46.15% 7.69% 88.89% 87.50% 8.33% 30.00% 0.00% 500.00% 140.00%
Operating Cash Flow Growth
-19.20% -22.53% 30.38% 1.93% 70.35% 63.38% -32.46% -0.55% 36.29% 24.66%
Free Cash Flow Firm Growth
21.14% -130.28% -39.74% 739.23% 43.70% 755.87% 315.33% -102.67% 1,708.98% 101.40%
Invested Capital Growth
-2.77% 3.12% 0.20% 1.31% -2.18% -2.76% -0.41% 0.95% -1.57% 0.18%
Revenue Q/Q Growth
1.56% 2.15% -1.65% 3.09% 0.34% 1.65% 0.37% 0.60% 1.86% 2.51%
EBITDA Q/Q Growth
-24.81% 10.64% -5.88% 4.56% -11.89% 7.92% 10.74% 0.81% -12.16% 11.01%
EBIT Q/Q Growth
-77.98% 41.11% -19.00% 20.79% -43.87% 21.18% 43.27% -3.92% -42.64% 35.60%
NOPAT Q/Q Growth
-15.97% 43.39% -23.69% 26.02% 4.60% -6.32% 52.48% 4.66% 30.09% -29.26%
Net Income Q/Q Growth
-14.64% 37.36% -20.26% 13.88% 18.70% -6.44% 57.57% 7.10% -33.20% 18.91%
EPS Q/Q Growth
-15.79% 35.71% -17.65% 13.33% 15.38% 0.00% 44.44% 12.50% -33.33% 20.00%
Operating Cash Flow Q/Q Growth
-41.60% 196.25% -69.19% 51.59% -44.01% 398.57% -75.91% 153.34% -46.30% 106.10%
Free Cash Flow Firm Q/Q Growth
450.19% -214.55% 197.66% 115.05% -12.48% 127.99% 3,257.75% -102.28% 421.26% 157.36%
Invested Capital Q/Q Growth
-4.52% -2.28% 1.58% -3.21% 1.27% -5.04% 2.71% -0.96% 0.67% -2.75%
Profitability Metrics
- - - - - - - - - -
Gross Margin
66.17% 66.52% 66.83% 66.17% 65.98% 66.47% 65.94% 65.40% 65.66% 65.26%
EBITDA Margin
20.92% 28.26% 26.09% 27.26% 23.54% 26.81% 25.25% 22.89% 22.19% 25.73%
Operating Margin
6.32% 8.89% 6.16% 7.82% 6.03% 6.91% 5.79% 4.19% 4.49% 3.54%
EBIT Margin
2.22% 10.23% 7.41% 8.99% 4.34% 7.75% 6.50% 4.56% 4.12% 7.32%
Profit (Net Income) Margin
6.58% 7.83% 5.82% 7.18% 6.50% 5.50% 5.97% 3.80% 3.57% 5.45%
Tax Burden Percent
89.16% 76.55% 78.64% 79.89% 84.73% 70.92% 91.84% 83.51% 74.92% 74.44%
Interest Burden Percent
332.79% 100.00% 100.00% 100.00% 176.97% 100.00% 100.00% 100.00% 115.72% 100.00%
Effective Tax Rate
10.84% 23.45% 21.36% 20.11% 15.27% 29.08% 8.16% 16.49% 25.08% 25.56%
Return on Invested Capital (ROIC)
6.18% 7.25% 4.93% 6.43% 5.23% 5.03% 5.19% 3.48% 3.23% 2.53%
ROIC Less NNEP Spread (ROIC-NNEP)
5.34% 6.29% 3.84% 5.39% 3.71% 4.40% 4.33% 3.12% 2.99% -0.49%
Return on Net Nonoperating Assets (RNNOA)
-1.28% -1.41% -0.72% -1.04% -0.71% -0.87% -0.68% -0.55% -0.52% 0.09%
Return on Equity (ROE)
4.89% 5.83% 4.21% 5.39% 4.52% 4.16% 4.50% 2.94% 2.71% 2.62%
Cash Return on Invested Capital (CROIC)
9.27% 3.07% 5.18% 4.27% 7.04% 7.19% 3.98% 2.34% 5.06% 2.37%
Operating Return on Assets (OROA)
1.28% 5.89% 4.26% 5.01% 2.43% 4.39% 3.67% 2.50% 2.23% 3.94%
Return on Assets (ROA)
3.80% 4.51% 3.35% 4.01% 3.64% 3.11% 3.37% 2.08% 1.94% 2.93%
Return on Common Equity (ROCE)
4.89% 5.83% 4.21% 5.39% 4.52% 4.16% 4.50% 2.94% 2.71% 2.62%
Return on Equity Simple (ROE_SIMPLE)
0.00% 5.54% 5.11% 5.17% 0.00% 3.82% 3.78% 3.52% 0.00% 2.80%
Net Operating Profit after Tax (NOPAT)
4.18 4.97 3.47 4.55 3.61 3.45 3.68 2.41 2.31 1.77
NOPAT Margin
5.63% 6.80% 4.85% 6.25% 5.11% 4.90% 5.32% 3.50% 3.37% 2.64%
Net Nonoperating Expense Percent (NNEP)
0.84% 0.96% 1.09% 1.04% 1.52% 0.63% 0.86% 0.36% 0.24% 3.02%
Return On Investment Capital (ROIC_SIMPLE)
1.16% - - - 1.06% - - - 0.69% -
Cost of Revenue to Revenue
33.83% 33.48% 33.17% 33.83% 34.02% 33.53% 34.06% 34.60% 34.34% 34.74%
SG&A Expenses to Revenue
11.86% 11.57% 13.35% 11.42% 11.96% 13.21% 13.10% 12.86% 13.14% 13.52%
R&D to Revenue
17.08% 16.55% 16.88% 16.54% 16.90% 15.50% 15.94% 16.94% 17.23% 17.06%
Operating Expenses to Revenue
59.86% 57.63% 60.66% 58.35% 59.95% 59.55% 60.15% 61.21% 61.16% 61.72%
Earnings before Interest and Taxes (EBIT)
1.65 7.48 5.30 6.54 3.06 5.45 4.50 3.14 2.83 4.93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
16 21 19 20 17 19 17 16 15 17
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.69 2.47 2.43 2.34 2.39 1.93 2.20 2.45 2.26 1.95
Price to Tangible Book Value (P/TBV)
13.97 13.72 15.26 16.71 20.03 16.52 21.45 30.07 32.76 25.96
Price to Revenue (P/Rev)
3.32 3.05 2.97 2.85 2.92 2.38 2.74 3.04 2.82 2.46
Price to Earnings (P/E)
48.34 44.49 47.46 45.23 53.60 50.46 58.25 69.61 62.31 69.73
Dividend Yield
0.43% 0.46% 0.47% 0.48% 0.37% 0.35% 0.20% 0.00% 0.00% 0.00%
Earnings Yield
2.07% 2.25% 2.11% 2.21% 1.87% 1.98% 1.72% 1.44% 1.61% 1.43%
Enterprise Value to Invested Capital (EV/IC)
3.32 2.90 2.77 2.67 2.76 2.19 2.46 2.78 2.52 2.15
Enterprise Value to Revenue (EV/Rev)
2.98 2.76 2.73 2.61 2.67 2.11 2.52 2.81 2.60 2.24
Enterprise Value to EBITDA (EV/EBITDA)
11.65 10.19 10.21 9.82 10.83 8.61 10.41 11.81 10.91 9.88
Enterprise Value to EBIT (EV/EBIT)
41.49 32.18 34.30 33.66 46.07 35.66 43.54 50.77 45.90 49.83
Enterprise Value to NOPAT (EV/NOPAT)
50.67 47.91 51.57 48.20 56.53 49.22 68.63 85.10 71.95 84.39
Enterprise Value to Operating Cash Flow (EV/OCF)
15.09 13.20 11.83 11.46 11.63 10.02 14.16 14.88 13.58 12.01
Enterprise Value to Free Cash Flow (EV/FCFF)
35.29 95.77 53.56 62.87 38.79 30.07 61.62 119.44 49.46 90.74
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.05 0.05 0.06 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.05 0.05 0.06 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.24 -0.22 -0.19 -0.19 -0.19 -0.20 -0.16 -0.17 -0.17 -0.19
Leverage Ratio
1.44 1.43 1.44 1.49 1.48 1.46 1.46 1.50 1.46 1.45
Compound Leverage Factor
4.80 1.43 1.44 1.49 2.62 1.46 1.46 1.50 1.69 1.45
Debt to Total Capital
0.00% 4.81% 5.10% 5.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 4.81% 5.10% 5.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 95.19% 94.90% 94.65% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.23 0.25 0.26 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 -1.04 -0.89 -0.91 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.23 0.25 0.26 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 1.08 1.24 1.27 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 -4.87 -4.52 -4.46 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 1.08 1.24 1.27 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
4.80 4.57 4.33 3.81 3.94 3.41 3.79 3.75 3.54 3.37
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.32 1.32 1.24 1.17 1.10 1.11 1.08 1.03 0.98 0.99
Quick Ratio
1.15 1.14 1.07 1.01 0.93 0.93 0.89 0.88 0.82 0.80
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
12 -3.33 2.91 0.98 9.63 11 4.82 -0.15 6.70 1.29
Operating Cash Flow to CapEx
163.23% 279.44% 96.21% 269.78% 209.27% 367.37% 79.22% 243.23% 132.05% 253.17%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.58 0.58 0.57 0.56 0.56 0.57 0.56 0.55 0.54 0.54
Accounts Receivable Turnover
7.91 8.66 7.40 6.19 6.88 8.21 7.23 6.14 6.87 8.28
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
24.56 23.39 21.66 20.78 19.59 18.98 17.71 17.03 15.96 15.45
Accounts Payable Turnover
13.90 24.32 6.87 7.53 12.88 7.35 4.66 4.91 14.69 4.09
Days Sales Outstanding (DSO)
46.16 42.13 49.31 58.93 53.07 44.45 50.48 59.44 53.10 44.07
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
26.26 15.01 53.16 48.46 28.33 49.64 78.35 74.36 24.86 89.32
Cash Conversion Cycle (CCC)
19.90 27.12 -3.85 10.47 24.74 -5.18 -27.87 -14.91 28.24 -45.25
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
262 275 281 277 270 266 280 273 276 274
Invested Capital Turnover
1.10 1.07 1.02 1.03 1.02 1.03 0.98 1.00 0.96 0.96
Increase / (Decrease) in Invested Capital
-7.48 8.30 0.56 3.57 -6.02 -7.55 -1.14 2.57 -4.39 0.49
Enterprise Value (EV)
870 796 779 738 744 584 689 760 695 589
Market Capitalization
967 877 847 806 815 660 750 823 753 645
Book Value per Share
$11.82 $11.69 $11.49 $11.38 $11.25 $11.15 $11.10 $10.99 $10.93 $10.80
Tangible Book Value per Share
$2.28 $2.10 $1.83 $1.59 $1.34 $1.30 $1.14 $0.90 $0.75 $0.81
Total Capital
359 373 368 364 341 342 341 336 334 330
Total Debt
0.00 18 19 19 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 18 19 19 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-97 -81 -68 -68 -71 -76 -60 -63 -58 -56
Capital Expenditures (CapEx)
6.84 6.84 6.71 7.76 6.60 6.72 6.25 8.45 6.14 5.96
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-60 -60 -56 -62 -59 -60 -47 -55 -57 -53
Debt-free Net Working Capital (DFNWC)
37 35 27 21 12 12 8.86 4.10 -2.84 -1.04
Net Working Capital (NWC)
37 35 27 21 12 12 8.86 4.10 -2.84 -1.04
Net Nonoperating Expense (NNE)
-0.71 -0.75 -0.70 -0.68 -0.98 -0.42 -0.45 -0.21 -0.14 -1.89
Net Nonoperating Obligations (NNO)
-97 -81 -68 -68 -71 -76 -60 -63 -58 -56
Total Depreciation and Amortization (D&A)
14 13 13 13 14 13 13 13 12 12
Debt-free, Cash-free Net Working Capital to Revenue
-20.50% -20.77% -19.55% -22.04% -21.24% -21.48% -17.19% -20.17% -21.27% -20.14%
Debt-free Net Working Capital to Revenue
12.83% 12.18% 9.55% 7.54% 4.25% 4.44% 3.23% 1.52% -1.06% -0.40%
Net Working Capital to Revenue
12.83% 12.18% 9.55% 7.54% 4.25% 4.44% 3.23% 1.52% -1.06% -0.40%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Adjusted Weighted Average Basic Shares Outstanding
30.39M 30.41M 30.40M 30.31M 30.57M 30.68M 30.68M 30.59M 30.65M 30.57M
Adjusted Diluted Earnings per Share
$0.16 $0.19 $0.14 $0.17 $0.15 $0.13 $0.13 $0.09 $0.08 $0.12
Adjusted Weighted Average Diluted Shares Outstanding
30.54M 30.59M 30.53M 30.42M 30.67M 30.77M 30.78M 30.66M 30.72M 30.66M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
30.43M 30.41M 30.41M 30.40M 30.30M 30.29M 30.69M 30.68M 30.58M 30.57M
Normalized Net Operating Profit after Tax (NOPAT)
4.18 4.97 3.47 4.55 3.61 3.45 3.68 2.41 2.31 1.77
Normalized NOPAT Margin
5.63% 6.80% 4.85% 6.25% 5.11% 4.90% 5.32% 3.50% 3.37% 2.64%
Pre Tax Income Margin
7.38% 10.23% 7.41% 8.99% 7.68% 7.75% 6.50% 4.56% 4.77% 7.32%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
17.01% 16.78% 18.06% 21.93% 20.10% 17.60% 11.92% 0.00% 0.00% 0.00%
Augmented Payout Ratio
17.01% 53.72% 18.06% 21.93% 78.79% 30.21% 11.92% 0.00% 191.36% 304.11%

Frequently Asked Questions About HealthStream's Financials

When does HealthStream's financial year end?

According to the most recent income statement we have on file, HealthStream's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has HealthStream's net income changed over the last 10 years?

HealthStream's net income appears to be on an upward trend, with a most recent value of $20.01 million in 2024, rising from $10.39 million in 2014. The previous period was $15.21 million in 2023. See where experts think HealthStream is headed by visiting HealthStream's forecast page.

What is HealthStream's operating income?
HealthStream's total operating income in 2024 was $21.29 million, based on the following breakdown:
  • Total Gross Profit: $193.71 million
  • Total Operating Expenses: $172.42 million
How has HealthStream revenue changed over the last 10 years?

Over the last 10 years, HealthStream's total revenue changed from $170.69 million in 2014 to $291.65 million in 2024, a change of 70.9%.

How much debt does HealthStream have?

HealthStream's total liabilities were at $151.41 million at the end of 2024, a 4.9% decrease from 2023, and a 69.4% increase since 2014.

How much cash does HealthStream have?

In the past 9 years, HealthStream's cash and equivalents has ranged from $36.57 million in 2020 to $134.32 million in 2018, and is currently $59.47 million as of their latest financial filing in 2024.

How has HealthStream's book value per share changed over the last 10 years?

Over the last 10 years, HealthStream's book value per share changed from 6.07 in 2014 to 11.82 in 2024, a change of 94.5%.



This page (NASDAQ:HSTM) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners